Complications of MRSA Treatment: Linezolid-induced Myelosuppression Presenting with Pancytopenia

Methicillin-resistant Staphylococcus aureus (MRSA) infections have grown to epidemic proportions in the United States. With the development of increasing drug resistance of MRSA to traditional antimicrobials, there has been a search for a more effective antibiotic treatment. Linezolid is one of the...

Descripción completa

Detalles Bibliográficos
Autores principales: Gorchynski, Julie, Rose, Jeri K
Formato: Texto
Lenguaje:English
Publicado: Department of Emergency Medicine, University of California, Irvine School of Medicine 2008
Materias:
Infectious Disease
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2672264/
https://www.ncbi.nlm.nih.gov/pubmed/19561739
_version_ 1782166504001765376
author Gorchynski, Julie
Rose, Jeri K
author_facet Gorchynski, Julie
Rose, Jeri K
author_sort Gorchynski, Julie
collection PubMed
description Methicillin-resistant Staphylococcus aureus (MRSA) infections have grown to epidemic proportions in the United States. With the development of increasing drug resistance of MRSA to traditional antimicrobials, there has been a search for a more effective antibiotic treatment. Linezolid is one of the most effective oral medications used for outpatient treatment of MRSA infections. We present a case of pancytopenia after outpatient treatment with linezolid. Myelosuppression is a rare but serious side effect of linezolid of which emergency physicians need to be aware in order to provide early intervention.
format Text
id pubmed-2672264
institution National Center for Biotechnology Information
language English
publishDate 2008
publisher Department of Emergency Medicine, University of California, Irvine School of Medicine
record_format MEDLINE/PubMed
spelling pubmed-26722642009-06-24 Complications of MRSA Treatment: Linezolid-induced Myelosuppression Presenting with Pancytopenia Gorchynski, Julie Rose, Jeri K West J Emerg Med Infectious Disease Methicillin-resistant Staphylococcus aureus (MRSA) infections have grown to epidemic proportions in the United States. With the development of increasing drug resistance of MRSA to traditional antimicrobials, there has been a search for a more effective antibiotic treatment. Linezolid is one of the most effective oral medications used for outpatient treatment of MRSA infections. We present a case of pancytopenia after outpatient treatment with linezolid. Myelosuppression is a rare but serious side effect of linezolid of which emergency physicians need to be aware in order to provide early intervention. Department of Emergency Medicine, University of California, Irvine School of Medicine 2008-08 /pmc/articles/PMC2672264/ /pubmed/19561739 Text en Copyright © 2008 the authors. http://creativecommons.org/licenses/by-nc/4.0 This is an open access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY 4.0) License. See: http://creativecommons.org/licenses/by-nc/4.0/.
spellingShingle Infectious Disease
Gorchynski, Julie
Rose, Jeri K
Complications of MRSA Treatment: Linezolid-induced Myelosuppression Presenting with Pancytopenia
title Complications of MRSA Treatment: Linezolid-induced Myelosuppression Presenting with Pancytopenia
title_full Complications of MRSA Treatment: Linezolid-induced Myelosuppression Presenting with Pancytopenia
title_fullStr Complications of MRSA Treatment: Linezolid-induced Myelosuppression Presenting with Pancytopenia
title_full_unstemmed Complications of MRSA Treatment: Linezolid-induced Myelosuppression Presenting with Pancytopenia
title_short Complications of MRSA Treatment: Linezolid-induced Myelosuppression Presenting with Pancytopenia
title_sort complications of mrsa treatment: linezolid-induced myelosuppression presenting with pancytopenia
topic Infectious Disease
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2672264/
https://www.ncbi.nlm.nih.gov/pubmed/19561739
work_keys_str_mv AT gorchynskijulie complicationsofmrsatreatmentlinezolidinducedmyelosuppressionpresentingwithpancytopenia
AT rosejerik complicationsofmrsatreatmentlinezolidinducedmyelosuppressionpresentingwithpancytopenia

Ejemplares similares